A strategy for developing a hammerhead ribozyme for selective RNA cleavage depending on substitutional RNA editing

RNA

Volumn 18, Issue 9, 2012, Pages 1735-1744

  Fukuda, Masatora ^a   Kurihara, Kei ^a   Tanaka, Yasuyoshi ^a   Deshimaru, Masanobu ^a  

^a FUKUOKA UNIVERSITY   (Japan)

Author keywords

A to I RNA editing; C to U RNA editing; Hammerhead ribozyme; Substitutional RNA editing

Indexed keywords

ADENOSINE; APOLIPOPROTEIN B; CYTOSINE; FILAMIN A; HAMMERHEAD RIBOZYME; INOSINE; MESSENGER RNA; SEROTONIN RECEPTOR; URACIL;

ARTICLE; BASE PAIRING; GEL ELECTROPHORESIS; IN VITRO STUDY; PRIORITY JOURNAL; RNA CLEAVAGE; RNA DEGRADATION; RNA EDITING; RNA EXTRACTION; RNA STRUCTURE;

APOLIPOPROTEINS B; BASE SEQUENCE; CONTRACTILE PROTEINS; HEK293 CELLS; HUMANS; KINETICS; MICROFILAMENT PROTEINS; NUCLEIC ACID CONFORMATION; RNA CLEAVAGE; RNA EDITING; RNA, CATALYTIC;

EID: 84865143662     PISSN: 13558382     EISSN: 14699001     Source Type: Journal    
DOI: 10.1261/rna.033399.112     Document Type: Article

References (46)

1. Bass BL. 2002. RNA editing by adenosine deaminases that act on RNA. Annu Rev Biochem 71: 817-846. (Pubitemid 34800236)
2. Blanc V, Davidson NO. 2003. C-to-U RNA editing: mechanisms leading to genetic diversity. J Biol Chem 278: 1395-1398. (Pubitemid 36801361)
3. Burns CM, Chu H, Rueter SM, Hutchinson LK, Canton H, Sanders-Bush E, Emeson RB. 1997. Regulation of serotonin-2C receptor G-protein coupling by RNA editing. Nature 387: 303-308. (Pubitemid 27220768)
4. Campbell TB, McDonald CK, Hagen M. 1997. The effect of structure in a long target RNA on ribozyme cleavage efficiency. Nucleic Acids Res 25: 4985-4993. (Pubitemid 28022260)
5. Carbonell A, Flores R, Gago S. 2011. Trans-cleaving hammerhead ribozymes with tertiary stabilizing motifs: in vitro and in vivo activity against a structured viroid RNA. Nucleic Acids Res 39: 2432-2444.
6. Castanotto D, Li JR, Michienzi A, Langlois MA, Lee NS, Puymirat J, Rossi JJ. 2002. Intracellular ribozyme applications. Biochem Soc Trans 30: 1140-1145. (Pubitemid 36002425)
7. Chen SH, Habib G, Yang CY, Gu ZW, Lee BR, Weng SA, Silberman SR, Cai SJ, Deslypere JP, Rosseneu M, et al. 1987. Apolipoprotein B-48 is the product of a messenger RNA with an organ-specific inframe stop codon. Science 238: 363-366. (Pubitemid 17151728)
8. Chester A, Scott J, Anant S, Navaratnam N. 2000. RNA editing: cytidine to uridine conversion in apolipoprotein B mRNA. Biochim Biophys Acta 1494: 1-13.
9. Citti L, Rainaldi G. 2005. Synthetic hammerhead ribozymes as therapeutic tools to control disease genes. Curr Gene Ther 5: 11-24. (Pubitemid 40246739)
10. Dawson PA, Marini JC. 2000. Hammerhead ribozymes selectively suppress mutant type I collagen mRNA in osteogenesis imperfecta fibroblasts. Nucleic Acids Res 28: 4013-4020.
11. De la Peña M, Gago S, Flores R. 2003. Peripheral regions of natural hammerhead ribozymes greatly increase their self-cleavage activity. EMBO J 22: 5561-5570. (Pubitemid 37279965)
12. Eggington JM, Greene T, Bass BL. 2011. Predicting sites of ADAR editing in double-stranded RNA. Nat Commun 2: 319. doi: 10.1038/ncomms1324.
13. Farajollahi S, Maas S. 2010. Molecular diversity through RNA editing: a balancing act. Trends Genet 26: 221-230.
14. Gommans WM, Tatalias NE, Sie CP, Dupuis D, Vendetti N, Smith L, Kaushal R, Maas S. 2008. Screening of human SNP database identifies recoding sites of A-to-I RNA editing. RNA 14: 2074-2085.
15. Goodchild J. 2002. Hammerhead ribozymes for target validation. Expert Opin Ther Targets 6: 235-247. (Pubitemid 34477463)
16. Haseloff J, Gerlach WL. 1988. Simple RNA enzymes with new and highly specific endoribonuclease activities. Nature 334: 585-591.
17. Higuchi M, Single FN, Kohler M, Sommer B, Sprengel R, Seeburg PH. 1993. RNA editing of AMPA receptor subunit GluR-B: a basepaired intron-exon structure determines position and efficiency. Cell 75: 1361-1370. (Pubitemid 24021910)
18. Hormes R, Sczakiel G. 2002. The size of hammerhead ribozymes is related to cleavage kinetics: the role of substrate length. Biochimie 84: 897-903. (Pubitemid 35422916)
19. Khvorova A, Lescoute A, Westhof E, Jayasena SD. 2003. Sequence elements outside the hammerhead ribozyme catalytic core enable intracellular activity. Nat Struct Biol 10: 708-712. (Pubitemid 37052408)
20. 2+ binding. Biochemistry 30: 5145-5150.
21. Kore AR, Vaish NK, Kutzke U, Eckstein F. 1998. Sequence specificity of the hammerhead ribozyme revisited; the NHH rule. Nucleic Acids Res 26: 4116-4120. (Pubitemid 28418367)
22. Levanon EY, Hallegger M, Kinar Y, Shemesh R, Djinovic-Carugo K, Rechavi G, Jantsch MF, Eisenberg E. 2005. Evolutionarily conserved human targets of adenosine to inosine RNA editing. Nucleic Acids Res 33: 1162-1168. (Pubitemid 41439909)
23. Lewin AS, Drenser KA, Hauswirth WW, Nishikawa S, Yasumura D, Flannery JG, LaVail MM. 1998. Ribozyme rescue of photoreceptor cells in a transgenic rat model of autosomal dominant retinitis pigmentosa. Nat Med 4: 967-971. (Pubitemid 28364040)
24. Li JB, Levanon EY, Yoon JK, Aach J, Xie B, Leproust E, Zhang K, Gao Y, Church GM. 2009. Genome-wide identification of human RNA editing sites by parallel DNA capturing and sequencing. Science 324: 1210-1213.
25. 17. Nucleic Acids Res 26: 2279-2285.
26. Maas S, Rich A. 2000. Changing genetic information through RNA editing. Bioessays 22: 790-802.
27. Maas S, Kawahara Y, Tamburro KM, Nishikura K. 2006. A-to-I RNA editing and human disease. RNA Biol 3: 1-9.
28. Nishikura K. 2010. Functions and regulation of RNA editing by ADAR deaminases. Annu Rev Biochem 79: 321-349.
29. Nishimoto Y, Yamashita T, Hideyama T, Tsuji S, Suzuki N, Kwak S. 2008. Determination of editors at the novel A-to-I editing positions. Neurosci Res 61: 201-206.
30. Nurpeisov V, Hurwitz SJ, Sharma PL. 2003. Fluorescent dye terminator sequencing methods for quantitative determination of replication fitness of human immunodeficiency virus type 1 containing the codon 74 and 184 mutations in reverse transcriptase. J Clin Microbiol 41: 3306-3311. (Pubitemid 36842337)
31. Perriman R, Delves A, Gerlach WL. 1992. Extended target-site specificity for a hammerhead ribozyme. Gene 113: 157-163.
32. Powell LM, Wallis SC, Pease RJ, Edwards YH, Knott TJ, Scott J. 1987. A novel form of tissue-specific RNA processing produces apolipoprotein-B48 in intestine. Cell 50: 831-840.
33. Pullirsch D, Jantsch MF. 2010. Proteome diversification by adenosine to inosine RNA editing. RNA Biol 7: 205-212.
34. Riedmann EM, Schopoff S, Hartner JC, Jantsch MF. 2008. Specificity of ADAR-mediated RNA editing in newly identified targets. RNA 14: 1110-1118. (Pubitemid 351717491)
35. Scherr M, Grez M, Ganser A, Engels JW. 1997. Specific hammerhead ribozyme-mediated cleavage of mutant N-ras mRNA in vitro and ex vivo. Oligoribonucleotides as therapeutic agents. J Biol Chem 272: 14304-14313. (Pubitemid 27232844)
36. Scott WG, Finch JT, Klug A. 1995. The crystal structure of an all-RNA hammerhead ribozyme: a proposed mechanism for RNA catalytic cleavage. Cell 81: 991-1002.
37. Seeburg PH, Hartner J. 2003. Regulation of ion channel/neurotransmitter receptor function by RNA editing. Curr Opin Neurobiol 13: 279-283. (Pubitemid 36792239)
38. Serra MJ, Smolter PE, Westhof E. 2004. Pronounced instability of tandem IU base pairs in RNA. Nucleic Acids Res 32: 1824-1828. (Pubitemid 38832728)
39. Sommer B, Kohler M, Sprengel R, Seeburg PH. 1991. RNA editing in brain controls a determinant of ion flow in glutamate-gated channels. Cell 67: 11-19. (Pubitemid 121001421)
40. Tedeschi L, Lande C, Cecchettini A, Citti L. 2009. Hammerhead ribozymes in therapeutic target discovery and validation. Drug Discov Today 14: 776-783.
41. Uhlenbeck OC. 1987. A small catalytic oligoribonucleotide. Nature 328: 596-600. (Pubitemid 17103959)
42. Wang AB, Liu DP, Liang CC. 2003. Regulation of human apolipoprotein B gene expression at multiple levels. Exp Cell Res 290: 1-12.
43. Werner M, Uhlenbeck OC. 1995. The effect of base mismatches in the substrate recognition helices of hammerhead ribozymes on binding and catalysis. Nucleic Acids Res 23: 2092-2096.
44. Werry TD, Loiacono R, Sexton PM, Christopoulos A. 2008. RNA editing of the serotonin 5HT2C receptor and its effects on cell signalling, pharmacology and brain function. Pharmacol Ther 119: 7-23.
45. Zoumadakis M, Tabler M. 1995. Comparative analysis of cleavage rates after systematic permutation of the NUXY consensus target motif for hammerhead ribozymes. Nucleic Acids Res 23: 1192-1196.
46. Zoumadakis M, Neubert WJ, Tabler M. 1994. The influence of imperfectly paired helices I and III on the catalytic activity of hammerhead ribozymes. Nucleic Acids Res 22: 5271-5278.